Observational study / 2023
Higher consumption of ultra-processed foods was linked to an increased risk of multimorbidity of cancer and cardiometabolic diseases.
In the EPIC prospective cohort study of 266,666 participants free of cancer, cardiovascular disease, and type 2 diabetes at baseline, diet was assessed via food-frequency questionnaires and categorized by the Nova classification. Over a median of 11.2 years, 4,461 participants developed multimorbidity of cancer and cardiometabolic diseases. Higher ultra-processed food (UPF) consumption (per 1 SD increment, ~260 g/day without alcoholic drinks) was associated with an increased risk of multimorbidity (HR: 1.09, 95% CI: 1.05, 1.12). Among subgroups, associations were notable for animal-based products (HR: 1.09, 95% CI: 1.05, 1.12) and artificially and sugar-sweetened beverages (HR: 1.09, 95% CI: 1.06, 1.12), while ultra-processed breads and cereals and plant-based alternatives showed no increased risk.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 266,666 participants (60% women) from seven European countries in the EPIC study
- What was measured
- Multimorbidity (co-occurrence of >=2 chronic diseases among first cancer, CVD, and T2D)
THE PAPER
Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study.
Cordova R, Viallon V, Fontvieille E, Peruchet-Noray L, Jansana A, Wagner KH, Kyrø C, Tjønneland A, Katzke V, Bajracharya R, Schulze MB, Masala G, Sieri S, Panico S, Ricceri F, Tumino R, Boer JMA, Verschuren WMM, van der Schouw YT, Jakszyn P, Redondo-Sánchez D, Amiano P, Huerta JM, Guevara M, Borné Y, Sonestedt E, Tsilidis KK, Millett C, Heath AK, Aglago EK, Aune D, Gunter MJ, Ferrari P, Huybrechts I, Freisling H. Lancet Reg Health Eur, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.